UK markets closed

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7100+0.0900 (+3.44%)
As of 01:00PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-48,916
-42,126
-20,823
-15,044
Depreciation & amortisation
535
479
351
215
Stock-based compensation
4,232
3,465
467
247
Change in working capital
2,169
2,150
1,466
-2,160
Accounts payable
1,420
38
1,027
-884
Other working capital
-43,028
-37,221
-19,389
-17,690
Other non-cash items
-
-
-
-815
Net cash provided by operating activities
-41,826
-36,032
-18,539
-17,557
Cash flows from investing activities
Investments in property, plant and equipment
-1,202
-1,189
-850
-133
Net cash used for investing activities
-1,202
-1,189
-850
-133
Cash flows from financing activities
Common stock issued
-
136,120
-
-
Net cash used provided by (used for) financing activities
136,216
216,006
1,427
36,890
Net change in cash
93,188
178,785
-17,962
19,200
Cash at beginning of period
84,451
11,194
29,156
9,956
Cash at end of period
177,639
189,979
11,194
29,156
Free cash flow
Operating cash flow
-41,826
-36,032
-18,539
-17,557
Capital expenditure
-1,202
-1,189
-850
-133
Free cash flow
-43,028
-37,221
-19,389
-17,690